Back to top
more

II-VI Incorporated (IIVI)

(Delayed Data from NSDQ)

$40.40 USD

40.40
990,748

+2.31 (6.06%)

Updated May 3, 2019 04:00 PM ET

After-Market: $40.39 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

AptarGroup's (ATR) Earnings & Sales Beat Estimates in Q2

by Zacks Equity Research

AptarGroup's (ATR) core sales growth in the Pharma segment in Q2 is partly offset by decline in core sales in other segments due to the coronavirus pandemic.

Plug Power (PLUG) to Post Q2 Earnings: What's in the Offing?

by Zacks Equity Research

Plug Power's (PLUG) Q2 results are expected to reflect gains from the growing popularity of fuel-cell engines. Supply-chain disruptions, high costs and forex woes might have been dragging.

Parker-Hannifin (PH) to Post Q4 Earnings: Is a Beat in Store?

by Zacks Equity Research

Strength in power, semiconductor, marine and mining end-markets are expected to have boosted Parker-Hannifin's (PH) fiscal Q4 performance. Soft aerospace, and oil and gas space might have been drags.

Sreoshi Bera headshot

US Manufacturing Activity Hits 15-Month High in July: 5 Picks

by Sreoshi Bera

Here are five stocks that are poised to grow on expansion in U.S. manufacturing activities.

What's in the Cards for Axon Enterprise (AAXN) Q2 Earnings?

by Zacks Equity Research

Axon Enterprise's (AAXN) second-quarter results are likely to reflect strong demand for TASER 7 device, Axon Cloud software offerings and Axon Body 3.

Caterpillar (CAT) Q2 Earnings & Revenues Surpass Estimates

by Zacks Equity Research

Caterpillar's (CAT) second-quarter adjusted earnings and sales both decline year over year due to lower demand across the board.

John Bean (JBT) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

John Bean (JBT) witnessed decline in revenue and earnings in the second quarter of 2020 due to weak demand owing to the coronavirus pandemic.

Terex (TEX) Posts Narrower-Than-Expected Loss in Q2

by Zacks Equity Research

Terex (TEX) is focused on aligning its production plans in response to the dismal customer demand due to the coronavirus pandemic.

Earnings Estimates Rising for II-VI (IIVI): Will It Gain?

by Zacks Equity Research

II-VI (IIVI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Lincoln Electric (LECO) Q2 Earnings & Revenues Top Estimates

by Zacks Equity Research

Lincoln Electric's (LECO) second-quarter earnings and sales both declined on a year-over-year basis on account of low demand due to the coronavirus impact and a weak industrial sector.

Rexnord (RXN) June-End Quater Earnings Beat, Decline Y/Y

by Zacks Equity Research

Rexnord's (RXN) June-end quarter's earnings surpass estimates but decline year over year. The results reflect the adverse impacts of the pandemic on organic sales and forex woes.

Packaging Corp's (PKG) Q2 Earnings Top Estimates, Down Y/Y

by Zacks Equity Research

Packaging Corp's (PKG) Q2 earnings decline, year over year, on lower prices and mix in the Packaging and Paper segments, dismal volumes in the Paper segment and higher depreciation expense.

Rockwell's (ROK) Q2 Earnings & Sales Top Estimates, View Up

by Zacks Equity Research

Rockwell (ROK) projects fiscal 2020 adjusted earnings per share at $7.40-$7.60.

Avery Dennison (AVY) Q2 Earnings & Revenues Beat Estimates

by Zacks Equity Research

Avery Dennison (AVY) anticipates a year-over-year drop in both revenue and earnings in 2020 owing to low demand.

Silgan (SLGN) Q2 Earnings & Revenues Top Estimates, View Up

by Zacks Equity Research

Silgan (SLGN) puts up a stellar show in Q2 on solid demand for food, health and hygiene products.

Grainger (GWW) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Grainger's (GWW) second-quarter 2020 earnings reflect lower volumes and lower operating earnings.

Pentair (PNR) Beats on Q2 Earnings & Sales, Initiates Guidance

by Zacks Equity Research

Pentair (PNR) delivers better-than-expected Q2 performance and projects adjusted earnings per share (EPS) between $2.00 and $2.20 for the current year.

Standex (SXI) Acquires Renco Electronics for $28M in Cash

by Zacks Equity Research

Standex's (SXI) buyout of Renco Electronics is likely to boost its earnings and consolidated free cash flow in the first year of the completion.

Stanley Black's (SWK) Board Okays 1.4% Hike in Dividend Rate

by Zacks Equity Research

Stanley Black (SWK) rewards shareholders with a 1.4% hike in the quarterly dividend rate. This underpins its strong cash position.

II-VI Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research

II-VI has been struggling lately, but the selling pressure may be coming to an end soon.

Crown Holdings (CCK) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

Strong demand for beverage cans in North America negated by weaker demand in other areas owing to the coronavirus pandemic are likely to get reflected in Crown Holdings' (CCK) Q2 results.

Alcoa's (AA) Unit Closes $750M Worth Senior Notes Offering

by Zacks Equity Research

Alcoa's (AA) subsidiary closes the offering of $750 million worth of senior notes. The proceeds will be used for boosting its cash balance and satisfying corporate purposes.

Cintas' (CTAS) First Aid & Safety Segment Launches ZOLL AED 3

by Zacks Equity Research

Cintas (CTAS) is likely to gain from solid product offerings and innovation abilities. It recently launches ZOLL AED 3, enabling rescuers to quickly provide effective treatment to cardiac emergencies.

Alcoa Provides Q2 Preliminary Results, Prices Debt Offerings

by Zacks Equity Research

Alcoa (AA) gains from improved productivity and cost-reduction measures in second-quarter 2020, per its preliminary results. Also, its subsidiary offers senior notes.

Emerson's (EMR) Growth Momentum Slows on Pandemic Scares

by Zacks Equity Research

Emerson (EMR) suffers from the adverse impacts of the pandemic and expects a year-over-year sales decline of 9-11% for fiscal 2020. High debts and forex woes are also concerning.